RECRUITING

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.

Official Title

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

Quick Facts

Study Start:2025-04-07
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06690099

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Willing and able to provide written informed consent
  2. 2. 18 years of age or older at enrollment
  3. 3. Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age
  4. 4. Women with RhD negative antigen status by serology
  5. 5. Willing to provide neonatal ABO and RhD genotyping status
  1. 1. Women with multiple gestation pregnancy

Contacts and Locations

Study Contact

Tasha Kalista Sr. Director, Clinical Affairs
CONTACT
8135508310
tasha.kalista@devyser.us.com

Study Locations (Sites)

Ochsner Health
New Orleans, Louisiana, 70115
United States

Collaborators and Investigators

Sponsor: Devyser Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-07
Study Completion Date2026-12

Study Record Updates

Study Start Date2025-04-07
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • RhD negative
  • fetal DNA
  • cell free fetal DNA
  • Fetal RhD genotype

Additional Relevant MeSH Terms

  • Rhesus D Genotype
  • Pregnancy